Related Experiment Videos
[Chronic granulomatous disease diagnosis: Patients and carriers]
Nadia Gisela Ramírez-Vargas1, Laura R Berrón-Ruiz, Renato Berrón-Pérez
1Unidad de Investigación en Inmunodeficiencias. Instituto Nacional de Pediatría. México, D. F.
Insights
Chronic granulomatous disease (CGD) is a primary immunodeficiency affecting phagocytosis. The 1,2,3-dihydrorhodamine (DHR) test aids in diagnosing CGD and identifying carriers, offering a simple, sensitive, and cost-effective screening method.
Area of Science:
- Immunology
- Genetics
- Clinical Diagnostics
Background:
- Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by defective phagocytosis, leading to recurrent infections and granulomas.
- CGD results from mutations in NADPH oxidase genes, impacting the enzyme's function.
- It has an estimated incidence of 1 in 250,000 live births and follows X-linked or autosomal recessive inheritance patterns.
Purpose of the Study:
- To summarize the diagnostic approaches for CGD.
- To highlight the importance of identifying CGD transmission patterns for genetic counseling.
- To emphasize the role of the 1,2,3-dihydrorhodamine (DHR) oxidation test in diagnosing CGD and identifying carriers.
Main Methods:
- Diagnosis involves direct measurement of superoxide production, including ferricytochrome c reduction, chemiluminescence, nitroblue tetrazolium reduction, or 1,2,3-dihydrorhodamine (DHR) oxidation.
- The DHR test is utilized to identify CGD transmission patterns and carriers of X-linked CGD.
Main Results:
- The DHR test is effective in identifying CGD transmission patterns and carriers.
- X-linked CGD carriers have an increased risk of developing autoimmune diseases.
Conclusions:
- Accurate diagnosis and identification of transmission patterns are crucial for genetic counseling in CGD.
- The DHR test is a valuable screening tool for CGD due to its ease of use, sensitivity, and low cost.
- Early identification of carriers is important for managing associated health risks, such as autoimmune diseases.
Abstract:
Chronic granulomatous disease (CGD) is a primary immunodeficiency, it has a defect in phagocytosis and its estimated incidence is 1 in 250,000 live births. Recurrent infections and granulomas are the most common clinical manifestations. CGD is caused by a functional defect in one of the subunits of the NADPH oxidase, the patients have mutations in NADPH genes. There are two patterns of transmission described in CGD, X-linked and autosomal recessive. The diagnosis of CGD is made by direct measurement of superoxide production, ferricytochrome c reduction, chemiluminescence, reduction of nitroblue tetrazolium or 1, 2, 3 dihydrorhodamine oxidation. After the diagnosis of CGD is important to identify the pattern of transmission in each case in order to provide genetic counseling to the patient's family, as well as inform Xlinked CGD carriers that have a major risk to develop autoimmune diseases. The 1, 2, 3, DHR help to identify the pattern of transmission and carriers of CGD Xlinked, it is considered as a screening method because of its easiness, sensitive and inexpensive cost.
Related Concept Videos
American Trypanosomiasis
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Inflammation: Introduction
Inflammatory Bowel Disease III: Crohn's Disease
Cryptococcal Meningitis
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History